← Back to Clinical Trials
Recruiting NCT07340554

Neuroimaging of Adolescent Cannabis Use Treatment

Trial Parameters

Condition Cannabis Use
Sponsor Indiana University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 80
Sex ALL
Min Age 14 Years
Max Age 17 Years
Start Date 2026-04
Completion 2030-05
Interventions
Contingency ManagementElastic Net Regression

Brief Summary

This study is testing whether brain activity related to learning can help predict how well teens respond to a treatment program designed to reduce cannabis use. Teens ages 14-17 will complete a brain scan and then take part in 10 weekly virtual sessions where they report cannabis use and complete drug tests at home. Participants can earn prizes for staying cannabis-free.

Eligibility Criteria

Inclusion Criteria: * 14-17 year old youth * Guardian 18 years or older * Youth is MRI-eligible: No metal implants, prosthetics, orthodontic devices, transdermal medication patches, piercings and/or hair or eyelash extensions that cannot easily be removed, metallic ink tattoos on the neck or face, or claustrophobia, and are not pregnant * Youth must endorse having used cannabis at least once per week over the past month OR youth must have been diagnosed with cannabis use disorder within the past three months Exclusion Criteria: * Youth has a history of Fetal Alcohol Spectrum Disorder, intellectual disorders, pervasive development disorder or autism spectrum disorder, psychotic disorders, history of neurological problems (epilepsy, traumatic brain injury, brain tumor, cerebrovascular disease) by parent/guardian report * Youth or caretaker who is monolingual non-English speaker * Youth who is currently experiencing active psychosis symptoms or suicidal/homicidal ideation or who has been

Related Trials